Back to search

Boston University

Identification of new targets for the treatment of head and neck cancer: N-glycosylation gene DPAGT1 and β-catenin/CBP signaling

Abstract

dc:description.abstract

Head and neck squamous cell carcinoma (HNSCC) is pernicious disease with majority of cases presenting as oral squamous cell carcinoma (OSCC). OSCC is characterized by tumor heterogeneity, locoregional metastases and resistance to existing treatments. OSCC five-year overall survival rates are currently ~ 50 % with few therapeutic options available. Cancers are typically associated with dysregulated signaling pathways that normally have vital roles in embryonic development and hemostasis. We have focused on two homeostatic pathways, protein N-glycosylation and the canonical Wnt/β-catenin signaling, which have been shown to converge on each other’s activities. These pathways, when left unchecked, drive early pathogenesis and/or metastasis of a range of cancers, including OSCC. Aberrant activation of the DPAGT1 gene, encoding a key regulatory enzyme that functions at the first committed step in the protein N-glycosylation pathway, has been shown to be associated with OSCC. In OSCC, high DPAGT1 expression drives hyper-glycosylation of E-cadherin and loss of intercellular adhesion. Here, we provide evidence that ectopic expression of DPAGT1 in indolent OSCC CAL27 cells induced epithelial-to-mesenchymal transition (EMT) by upregulation of a key transcription factor, ZEB1, and mesenchymal protein, vimentin, coincident with increased cell migration. In contrast, partial knockdown of DPAGT1 in metastatic OSCC HSC-3 cells reduced expression of the EMT markers, diminished cell migration and enhanced intercellular adhesion. Further, inhibition of the DPAGT1 enzyme, GPT, with tunicamycin interfered with orthotopic tongue tumor growth and metastasis in nude mice coincident with diminished expression of vimentin- positive cells invading the tongue stroma. One mechanism responsible for increased DPAGT1 expression in OSCC is transcriptional activation by β-catenin. We now show that blocking transcriptional activity of β-catenin by interfering with its interaction with the cAMP-responsive element binding (CREB)-binding protein (CBP) using a small molecule inhibitor, ICG-001, inhibited cell proliferation and mesenchymal cell phenotypes in cellular models. In addition, ICG-001 abrogated tumor growth and metastases in zebrafish and murine models. Microarray analyses of ICG-001 gene expression signature revealed inhibition of genes involved in cell proliferation, survival, stemness, as well as N-glycosylation, but upregulation of genes functioning in cell adhesion and cell polarity. Importantly, the ICG-001 inhibition-associated transcriptional signature tracked with advanced tumor grade and poor survival in human patients. Our studies provide the first evidence that aberrant activation of DPAGT1 and β-catenin signaling promotes aggressive traits of OSCC cells and suggest that targeting the β-catenin/CBP interaction in the nucleus may provide an effective novel strategy for OSCC therapy.

Degree

thesis:*
Name thesis:degree_name
Doctor of Science (D.Sc.)
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Molecular & Cell Biology
Grantor
Boston University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Abalkhail, Khalid A.
Advisor dc:contributor.advisor
  • Kukuruzinska, Maria A.
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/41349

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Abalkhail, Khalid A.. Identification of new targets for the treatment of head and neck cancer: N-glycosylation gene DPAGT1 and β-catenin/CBP signaling. doctoral thesis, Boston University, 2020. https://hdl.handle.net/2144/41349